Optimizing PEG-interferon and ribavirin combination therapy for patients infected with HCV-2 or HCV-3: is the puzzle completed?

J Hepatol. 2004 Jun;40(6):1032-5. doi: 10.1016/j.jhep.2004.04.008.
No abstract available

Publication types

  • Comment
  • Editorial
  • Review

MeSH terms

  • Antiviral Agents / therapeutic use
  • Drug Therapy, Combination
  • Hepatitis B / drug therapy*
  • Hepatitis B virus / classification*
  • Hepatitis B virus / drug effects*
  • Humans
  • Interferons / therapeutic use*
  • Ribavirin / therapeutic use*

Substances

  • Antiviral Agents
  • Ribavirin
  • Interferons